Asma al-Assad, the wife of embattled Syrian President Bashar al-Assad, has been diagnosed with acute myeloid leukemia and will step back from her public duties for treatment.
Syrian first lady Asma al-Assad, a prominent figure in the country's political and social landscape, has been diagnosed with leukemia and will temporarily suspend her public appearances to undergo treatment.
In a statement released on Tuesday by her husband's office, it was announced that Asma al-Assad has been diagnosed with acute myeloid leukemia and will adhere to a specialized treatment plan that includes stringent infection prevention measures.
The news of the first lady's diagnosis has sent shockwaves through Syria, where she has been a vocal advocate for her husband's regime and a visible symbol of the country's struggle amidst the ongoing civil war. Asma al-Assad, a British-born citizen of Syrian descent, has been actively involved in charitable work and has frequently made public appearances, hosting meetings with the families of fallen soldiers and accompanying her husband on diplomatic visits.
Born in London to Syrian parents, Asma al-Assad met her future husband through family connections, and the couple married in 2000 when Bashar took office as president. Prior to her foray into public life, Asma worked as an investment banker at J.P. Morgan.
In the wake of the Syrian civil war's outbreak in 2011, Asma al-Assad emerged as a key figure in her husband's regime, championing national interests and standing by his side amidst accusations of war crimes.
Despite the ongoing conflict and international pressure, Asma al-Assad has remained a prominent public figure, making frequent appearances and hosting events. Her diagnosis with leukemia has raised concerns about her health and the potential impact on her public role.
The first lady has faced health challenges in the past, having been diagnosed with breast cancer in 2018. She was declared cancer-free in 2019 after undergoing treatment.
The news of Asma al-Assad's leukemia diagnosis has elicited mixed reactions. Some have expressed sympathy and prayers for her recovery, while others have questioned the timing of the announcement, suggesting it could be a ploy to garner support for her husband's regime.
Regardless of the political implications, Asma al-Assad's diagnosis highlights the personal toll that the ongoing conflict in Syria has taken on its citizens, including those at the highest echelons of power. It remains to be seen how her treatment will progress and what impact it will have on her public and private life.
